https://doi.org/10.4081/monaldi.2023.2576
Post-extubation high-flow nasal cannula oxygen therapy versus non-invasive ventilation in chronic obstructive pulmonary disease with hypercapnic respiratory failure
Submitted: March 7, 2023
Accepted: July 4, 2023
Published: July 28, 2023
Accepted: July 4, 2023
Abstract Views: 1550
PDF: 329
SUPPLEMENTARY MATERIAL: 17
SUPPLEMENTARY MATERIAL: 17
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The sequential use of non-invasive ventilation (NIV) for weaning in hypercapnic respiratory failure patients is a recommended practice. However, the effectiveness of weaning on high-flow nasal cannula (HFNC) is unclear. Chronic obstructive pulmonary disease patients with hypercapnic respiratory failure who received invasive ventilation were screened for enrollment. This study was a single-center, prospective, randomized comparative study. The primary outcome was treatment failure within 72 hours after extubation. Patients who were screened positive for extubation were enrolled in the study and randomized into the HFNC group and the NIV group using a computer-generated simple randomization chart. Treatment failure was defined as a return to invasive mechanical ventilation or a switch in respiratory support modality (i.e., changing from HFNC to NIV or from NIV to HFNC). The study included 62 of the 72 patients. Treatment failure occurred in 8 patients (26.67%) in the HFNC group and 8 patients in the NIV group (25%) (p=0.881). The mean duration of intensive care unit stay in the HFNC group was 5.47±2.26 days and 6.56±3.39 in the NIV group (p=0.376). In the current study, HFNC was non-inferior to NIV in preventing post-extubation respiratory failure in chronic obstructive pulmonary disease patients, while HFNC had better treatment tolerance.
Wakatsuki M, Sadler P. Invasive mechanical ventilation in acute exacerbation of COPD: Prognostic indicators to support clinical decision making. J Intensive Care Soc 2012;13:238-43.
Ferrer M, Sellarés J, Valencia M, et al. Articles non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet 374:1082-8.
Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Role of non invasive positive-pressure ventilation in post extubation respiratory failure: a meta-analysis. Respir Care 2007;52:1472-9.
Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: Noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50:1602426.
Jing G, Li J, Hao D, et al. Comparison of high flow nasal cannula with non invasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing post extubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health 2019;42:217-25.
Tan D, Walline JH, Ling B, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care 2020;24:489.
Boles JM, Bion J, Connors A, et al. Weaning from mechanical ventilation. Eur Respir J 2007;29:1033-56.
Vitacca M, Ambrosino N, Clini E, et al. Physiological response to pressure support ventilation delivered before and after extubation in patients not capable of totally spontaneous autonomous breathing. Am J Respir Crit Care Med 2001;164:638-41.
Burns KEA, Meade MO, Premji A, Adhikari NKJ. Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev 2013;2013:CD004127.
Lv Y, Lv Q, Lv Q, Lai T. Pulmonary infection control window as a switching point for sequential ventilation in the treatment of COPD patients: a meta-analysis. Int J Chron Obstruct Pulmon Dis 2017;12:1255-67.
Bräunlich J, Seyfarth HJ, Wirtz H. Nasal High-flow versus non-invasive ventilation in stable hypercapnic COPD: a preliminary report. Multidiscip Respir Med 2015;10:27.
Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J 2018;12:2046-56.
Feng Z, Zhang L, Yu H, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for AECOPD patients after extubation: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis 2022;17:1987-99.
Thille AW, Coudroy R, Nay MA, et al. Non-invasive ventilation alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone after extubation in COPD patients: a post hoc analysis of a randomized controlled trial. Ann Intensive Care 2021;11:30.
Yoo JW, Synn A, Huh JW, et al. Clinical efficacy of high-flow nasal cannula compared to noninvasive ventilation in patients with post-extubation respiratory failure. Korean J Intern Med 2016;31:82-8.
Mauri T, Galazzi A, Binda F, et al. Impact of flow and temperature on patient comfort during respiratory support by high-flow nasal cannula. Crit Care 2018;22:120.
Ethics Approval
The study was approved by the Institutional Ethics Committee (IEC/VMMC/SJH/Thesis/2021-05/CC-19 dated 11.06.2021)How to Cite
Ketan, Pankti Sheth, Rohit Kumar, Mahendran AJ, Pranav Ish, Shibdas Chakrabarti, Neeraj Kumar Gupta, and Nitesh Gupta. 2023. “Post-Extubation High-Flow Nasal Cannula Oxygen Therapy <i>versus< i> Non-Invasive Ventilation in Chronic Obstructive Pulmonary Disease With Hypercapnic Respiratory Failure”. Monaldi Archives for Chest Disease 94 (2). https://doi.org/10.4081/monaldi.2023.2576.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- E. Clini, F. Prato, M. Nobile, M. Bondi, B. Serri, C. Cilione, D. Lugli, Interdisciplinary rehabilitation in morbidly obese subjects: an observational pilot study , Monaldi Archives for Chest Disease: Vol. 65 No. 2 (2006): Pulmonary series
- M. Shameem, J. Akhtar, U. Baneen, N. Ahmad Khan, R. Bhargava, Z. Ahmed, M. Shahid, M. Azfar Siddiqui, Malignant melanoma presenting as an isolated pleural effusion , Monaldi Archives for Chest Disease: Vol. 75 No. 2 (2011): Pulmonary series
- F. Salajka, V. BartoÅ¡, J. Novosad, J. Å t'ásek, J. Bis, M. Brtko, P. Polanský, V. KoblÞek, V. Sedlák, Failure of noninvasive prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis , Monaldi Archives for Chest Disease: Vol. 75 No. 3 (2011): Pulmonary series
- Roberto F.E. Pedretti, Francesco Fattirolli, Raffaele Griffo, Marco Ambrosetti, Elisabetta Angelino, Silvia Brazzo, Ugo Corrà , Nicolò Dasseni, Pompilio Faggiano, Giuseppe Favretto, Oreste Febo, Marina Ferrari, Francesco Giallauria, Cesare Greco, Manuela Iannucci, Maria Teresa La Rovere, Mario Mallardo, Antonio Mazza, Massimo Piepoli, Carmine Riccio, Simonetta Scalvini, Luigi Tavazzi, Pier Luigi Temporelli, Gian Francesco Mureddu, Cardiac Prevention and Rehabilitation “3.0â€: From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR) , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Dimitrios Papadopoulos, Vlasios Skopas, Nikolaos Trakas, Eleni Papaefstathiou, Nikolaos Tzogas, Demosthenes Makris, Zoe Daniil, Konstantinos Gourgoulianis, Serum lactate dehydrogenase and its isoenzymes as predictors of clinical outcomes in acute exacerbation of chronic obstructive pulmonary disease: a retrospective analysis of a hospitalized cohort , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Anshul Mittal, Megha Varshney, Vidushi Rathi, Pranav Ish, High flow nasal cannula in acute hypercapnic exacerbation of chronic obstructive pulmonary disease: an emerging utility , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Zeynep Çınar, Eda Macit Aydın, Nurgul Naurzvai, Ayshan Mammadova, Sümeyye Kodalak, Aygül Abbasova, Gül Gürsel, Impact of neurological problems on mechanical ventilation and intensive care unit outcomes in pulmonary intensive care unit patients: a retrospective analysis of a single-center cohort , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Martino Pavone, Giovanni Misseri, Mariachiara Ippolito, Cesare Gregoretti, Renato Cutrera, New noninvasive modalities in long-term pediatric ventilation: a scoping review , Monaldi Archives for Chest Disease: Early Access
- Seyed Jalal Hashemi, Seyed Ali Javad Moosavi, Esmaeil Idani, Ali Javaherforoushzadeh, Hanieh Raji, Association of esophageal dilatation in chest CT scan with gastroesophageal reflux disease: A case control study , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Syed Muhammad Zubair, Muhammad Waleed Chaudhry, Ali Bin Sarwar Zubairi, Talha Shahzad, Aqusa Zahid, Ibrahim Ali Khan, Javaid Ahmed Khan, Muhammad Irfan, The effect of ivermectin on non-severe and severe COVID-19 disease and gender-based difference of its effectiveness , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
You may also start an advanced similarity search for this article.
